[
    [
        {
            "time": "2018-01-02",
            "original_text": "Health Secretary Alex Azar: ‘Bold action is on the way’ for drug prices",
            "features": {
                "keywords": [
                    "Health",
                    "Secretary",
                    "Alex",
                    "Azar",
                    "Bold",
                    "action",
                    "drug",
                    "prices"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Health Secretary Alex Azar: ‘Bold action is on the way’ for drug prices",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-25",
            "original_text": "United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q",
            "features": {
                "keywords": [
                    "United",
                    "Therapeutics",
                    "UTHR",
                    "Q1",
                    "Earnings",
                    "Rise",
                    "Sales",
                    "Drop"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-05-03",
            "original_text": "Teva Stock Rises on Strong 1Q18 Results, Outlook Up",
            "features": {
                "keywords": [
                    "Teva",
                    "Stock",
                    "Rises",
                    "Strong",
                    "1Q18",
                    "Results",
                    "Outlook",
                    "Up"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Teva Stock Rises on Strong 1Q18 Results, Outlook Up",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-15",
            "original_text": "Olumiant: A Key Drug in Rheumatoid Arthritis Indications",
            "features": {
                "keywords": [
                    "Olumiant",
                    "Key",
                    "Drug",
                    "Rheumatoid",
                    "Arthritis",
                    "Indications"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Olumiant: A Key Drug in Rheumatoid Arthritis Indications",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-10",
            "original_text": "Label Expansion May Boost Trulicity’s Revenues",
            "features": {
                "keywords": [
                    "Label",
                    "Expansion",
                    "Boost",
                    "Trulicity",
                    "Revenues"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Label Expansion May Boost Trulicity’s Revenues",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-20",
            "original_text": "Factors that Could Drive Trulicity’s Revenue Growth in 2018",
            "features": {
                "keywords": [
                    "Factors",
                    "Drive",
                    "Trulicity",
                    "Revenue",
                    "Growth",
                    "2018"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Factors that Could Drive Trulicity’s Revenue Growth in 2018",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]